Economic consequence of immediate testing for C-reactive protein and leukocyte count in new outpatients with acute infection

Clinica Chimica Acta

Volumn 360, Issue 1-2, 2005, Pages 114-121

  Takemura, Yuzuru ^a,b   Ishida, Haku ^c   Saitoh, Hiroki ^b   Kure, Hideki ^b   Kakoi, Hideo ^b   Ebisawa, Ken ^b   Kure, Morimitsu ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Nishi Ohmiya Hospital   (Japan)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute infection; Antibiotic prescription; C reactive protein; Cost effectiveness; Immediate testing; Leukocyte count

Indexed keywords

AMANTADINE; AMOXICILLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFACLOR; CEFAZOLIN; CEFCAPENE PIVOXIL; CEFOTIAM; CLARITHROMYCIN; ERYTHROMYCIN; FLOMOXEF; FOSFOMYCIN; LEVOFLOXACIN; NORFLOXACIN; OFLOXACIN; OSELTAMIVIR; PANIPENEM PLUS BETAMIPRON; ROKITAMYCIN; ZANAMIVIR;

ARTICLE; BLOOD ANALYSIS; BLOOD CHEMISTRY; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG COST; FEMALE; HEALTH ECONOMICS; HUMAN; INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; COST-BENEFIT ANALYSIS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; INFECTION; JAPAN; LEUKOCYTE COUNT; OUTPATIENTS; PRESCRIPTIONS, DRUG;

EID: 24044433595     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.04.017     Document Type: Article

References (22)

1. Y. Takemura, H. Kakoi, H. Ishida, H. Kure, Y. Tatsuguchi-Harada, and M. Sugawara Immediate availability of C-reactive protein and leukocyte count data influenced physicians' decisions to prescribe antimicrobial drugs for new outpatients with acute infections Clin Chem 50 2004 241 244
2. Takemura Y, Ebisawa K, Kakoi H, Saitoh H, Kure H, Ishida H, et al. Antibiotic selection patterns in acutely febrile new outpatients with or without immediate testing for C-reactive protein and leukocyte count. J Clin Pathol; in press.
3. B.S. Dahler-Eriksen, T. Lauritzen, J.F. Lassen, E.D. Lund, and I. Brandslund Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes Clin Chem 45 1999 478 485
4. P.M. Rainey Outcomes assessment for point-of-care testing Clin Chem 44 1998 1595 1596
5. C.P. Price Point of care testing BMJ 322 2001 1285 1288
6. F.D. Hobbs, B.C. Delaney, D.A. Fitzmaurice, S. Wilson, C.J. Hyde, and G.H. Thorpe A review of near patient testing in primary care Health Technol Assess 1 1997 1 229
7. C.P. Price Evidence-based laboratory medicine: supporting decision-making Clin Chem 46 2000 1041 1050
8. Y. Takemura, H. Ishida, Y. Inoue, and J.R. Beck Common diagnostic test panels for clinical evaluation of new primary care outpatients in Japan: a cost-effectiveness evaluation Clin Chem 45 1999 1752 1761
9. Y. Takemura, H. Ishida, Y. Inoue, and J.R. Beck Yield and cost of individual common diagnostic tests in new primary care outpatients in Japan Clin Chem 48 2002 42 54
10. P. Hjortdahl, S. Landaas, P. Urdal, M. Steinbakk, P. Fuglerud, and B. Nygaard C-reactive protein: a new rapid assay for managing infectious disease in primary health care Scand J Prim Health Care 9 1991 3 10
11. F.D. Hobbs, J.E. Kenkre, Y.H. Carter, G.H. Thorpe, and R.L. Holder Reliability and feasibility of a near patient test for C-reactive protein in primary care Br J Gen Pract 46 1996 395 400
12. B.S. Dahler-Eriksen, J.F. Lassen, P.H. Petersen, E.D. Lund, T. Lauritzen, and I. Brandslund Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots Clin Chem 43 1997 2064 2075
13. D.A. Seamark, S.N. Backhouse, and R. Powell Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein Ann Clin Biochem 40 2003 178 180
14. M.S. Gulich, A. Matschiner, R. Gluck, and H.P. Zeitler Improving diagnostic accuracy of bacterial pharyngitis by near patient measurement of C-reactive protein (CRP) Br J Gen Pract 49 1999 119 121
15. H.Z. Diederichsen, M. Skamling, A. Diederichsen, P. Grinsted, S. Antonsen, and P.H. Petersen Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice Scand J Prim Health Care 18 2000 39 43
16. R. Kawamoto, Y. Asai, N. Nago, M. Okayama, J. Mise, and M. Igarashi A study of clinical features and treatment of acute bronchitis by Japanese primary care physicians Fam Pract 15 1998 244 251
17. S. Teramoto, T. Matsuse, and Y. Fukuchi Public knowledge, attitudes, and experiences with antibiotic use for acute bronchitis Am J Med 110 2001 243 244
18. H.T. Sorensen, F.H. Steffensen, H.C. Schonheyder, P. Gron, and S. Sabroe Use of microbiological diagnostics and antibiotics in Danish general practice Int J Technol Assess Health Care 12 1996 745 751
19. T. Bergan Antibiotic usage in Nordic countries Int J Antimicrob Agents 18 2001 279 282
20. A. Vaccheri, L. Bjerrum, D. Resi, U. Bergman, and N. Montanaro Antibiotic prescribing in general practice: striking differences between Italy (Ravenna) and Denmark (Funen) J Antimicrob Chemother 50 2002 989 997
21. M.S. Fagan Can use of antibiotics in acute bronchitis be reduced? Tidsskr Nor Laegeforen 121 2001 455 458
22. Y. Takemura, H. Ishida, and Y. Inoue Utilization of common inflammatory markers in new, symptomatic, primary care outpatients based on their cost-effectiveness Clin Chem Lab Med 41 2003 668 674